Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
  • Subscribe
Submit An Article

Latest Articles

  • Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    Monash IVF joins M&A arms race with entry into Perth IVF market via acquisition
    • News

  • In an age where celebs own tequila brands, this one owns a hangover cure
    In an age where celebs own tequila brands, this one owns a hangover cure
    • News

  • Markets continue to recover, commodities lead the charge overnight
    Markets continue to recover, commodities lead the charge overnight
    • Market Update

  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
    Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap
    • Opinion

  • Crowd Media enters Silicon Valley partnership for interactive NFT collection
    Crowd Media enters Silicon Valley partnership for interactive NFT collection
    • News

  • MPower acquires Lakeland in $8m deal
    MPower acquires Lakeland in $8m deal
    • News

  • US market falls on Tech and Discretionary as Oil surges
    US market falls on Tech and Discretionary as Oil surges
    • Market Update

  • SportsHero launches eSports predictor in China to gamify eSports gambling
    SportsHero launches eSports predictor in China to gamify eSports gambling
    • News

  • This company is offering DNA tests for the whole family, including the dog!
    This company is offering DNA tests for the whole family, including the dog!
    • News

  • Regis Healthcare to claim back $14m spent on aged care COVID outbreaks
    Regis Healthcare to claim back $14m spent on aged care COVID outbreaks
    • News

Predictive test for diabetic kidney disease receives new patent

  • In News
  • March 24, 2022
  • Samantha Freidin
Predictive test for diabetic kidney disease receives new patent

12% of global health expenditure is spent on diabetes. That equates to approximately USD $673 billion. Scarily, 1 in 2 adults with diabetes is undiagnosed. 

Diabetic kidney disease (DKD) is directly caused by diabetes, and the damage the disease does to the kidneys. It is estimated that 1 in 3 diabetics will go on to develop DKD. Left unchecked, DKD can lead to dialysis or kidney transplant. 

DKD is a silent disease, with most sufferers unaware due to the lack of symptoms. Current standard of care tests involve blood and urine analysis to check for indications of disease. 

Proteomics International Laboratories (ASX: PIQ) have developed PromarkerD, the world’s first predictive diagnostic test specifically for DKD. The test analyses the patient’s blood for three specific biomarkers that indicate the early onset of DKD. The test also takes into consideration the patient’s age, HDL-cholesterol levels and glomerular filtration rate (kidney function). PIQ’s proprietary algorithm analyses these data points and delivers a patient risk report. The test has been clinically validated with studies published in multiple leading journals confirming that it can predict DKD disease up to 4 years in advance. The test is also CE Mark registered in Europe. 

Protecting their intellectual property, PromarkerD has patented their tech in multiple jurisdictions. The Company has today announced that they’ve added India to that list, where more than 74 million people live with diabetes. As the second largest diabetic population in the world (China is the largest), PIQ already has a strong existing footprint. 

The patent complements others already held by the Company, who’s intellectual property portfolio now covers 63% of the world’s population living with diabetes. 

Dr Richard Lipscombe, Managing Director of PIQ said: “Proteomics International has strong ties to India, having operated in the country since 2004. We’ve also taken part in multiple trade visits to India, connecting with the huge Indian biotechnology and pharma sectors.

“PromarkerD can help prevent the need for renal replacement therapies such as dialysis and kidney transplant, potentially saving global healthcare systems billions of dollars a year.”

The test is yet to be FDA approved with the regulatory body advising a De Novo classification pathway to approval. 

PIQ’s share price has jumped 3.57% just one hour after market open. The Company rounded out the December quarter with $4.5 million cash at hand. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022
  •  
  •  
  •  
  •  
  • asx piq
  • glomerular filtration
  • kidney disease
  • piq
  • promarkerd
  • Proteomics
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • In an age where celebs own tequila brands, this one owns a hangover cure - May 18, 2022
  • Pass go, collect mortgage: Why the Government’s latest first home buyer’s scheme is crap - May 17, 2022
  • This company is offering DNA tests for the whole family, including the dog! - May 16, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

Copyright © 2020 The Sentiment. All rights reserved.